Ayaka Isogai

6PUBLICATIONS
33CO-AUTHORS
Organisational, interpersonal and intercultural communicationCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2026
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.

|May 24, 2025
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer.

Ayaka Isogai, Mitsuo Terada, Yumi Wanifuchi-Endo

|Jan 01, 2025
Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.

Nanae Horisawa, Akiyo Yoshimura, Isao Oze

|May 26, 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.

Ayaka Isogai, Kazuki Nozawa, Akira Nakakami

|Jun 21, 2023
Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report.

Ayaka Isogai, Haruru Kotani, Masataka Sawaki

|Aug 29, 2022
Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use.

Yuka Endo, Akiyo Yoshimura, Masataka Sawaki

Pageof 1

Frequent Collaborators

5 joint publications

Kazuki Nozawa

3 joint publications

Yuka Endo

3 joint publications

Akiyo Yoshimura

3 joint publications

Masataka Sawaki